CLAIM #58538 · UnitedHealth Group Incorporated (UNH) · 2022Q2 earnings call · Jul 15, 2022 · due Dec 31, 2022
“We're going to be in the high 90s again this year with most of the book in right now.”
Heather Cianfrocco · Executive
In context
“selling season. So this is a really significant period for us in terms of the fit of the products and services that we're offering across the marketplace. One of the reasons why you've seen a step up our investment profile in the business is because we're seeing such a strong pickup in our services. And maybe with that, Heather, you could address specifically what you're seeing in Optum Rx as you think about selling seasons into '23? And maybe also just touch on the value-based care aspect that Lisa described. Heather Cianfrocco : Absolutely. As Andrew said, strong selling season across Optum Rx is enjoying that as well. And the way I think about that, first of all, it came off a really strong '22 season. Sitting where we are today, 2 ways to think about it. The first is client retention. We're going to be in the high 90s again this year with most of the book in right now. With respect to new business activity, based on sales activity, including finalists and win rates right now, we're ahead of where we were at this time last year. And I really think that's the result of the real-time innovation. We're working again with our clients now to bring them services today. We're not waiting. We're not waiting for other market factors or the environment to make us innovate and drive down cost, and that's showing up. I think we have the best client management team and responsive client management team in the industry, and that's paying off for us. So I think we're going to be very busy again in 2023. That's going to require some investment. But we're going to be very busy with another 2023 year serving our clients. With respect to value based, I guess, I think about”
Verify independently
SEC filings for UNH ↗ · Claim quote is verbatim from the 2022Q2 earnings call.